{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:14Z","timestamp":1762659854046,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cardinal Health Foundation","award":["009129-00001"],"award-info":[{"award-number":["009129-00001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.japh.2019.11.029","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T01:16:30Z","timestamp":1578532590000},"page":"497-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Implementation and assessment of a pilot, community pharmacy\u2013based, opioid pain medication management program"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4543-2363","authenticated-orcid":false,"given":"Vlada","family":"Manzur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Mirzaian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-4505","authenticated-orcid":false,"given":"Amy","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8389-2726","authenticated-orcid":false,"given":"Kimberly","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-4723","authenticated-orcid":false,"given":"Hollie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-6754","authenticated-orcid":false,"given":"Melissa","family":"Durham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2019.11.029_bib1","article-title":"Associations of nonmedical pain reliever use and initiation of heroin use in the United States","author":"Muhuri","year":"2013","journal-title":"CBHSQ Data Rev"},{"issue":"7","key":"10.1016\/j.japh.2019.11.029_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"March","key":"10.1016\/j.japh.2019.11.029_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","article-title":"Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study","volume":"160","author":"Carlson","year":"2016","journal-title":"Drug Alcohol Depend"},{"year":"2011","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","key":"10.1016\/j.japh.2019.11.029_bib5"},{"issue":"36","key":"10.1016\/j.japh.2019.11.029_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.japh.2019.11.029_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.japh.2019.11.029_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.sapharm.2019.01.002","article-title":"Pharmacist utilization of prescription opioid misuse interventions: acceptability among pharmacists and patients","volume":"15","author":"Riley","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"10.1016\/j.japh.2019.11.029_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ptdy.2017.05.025","article-title":"Pharmacists have a gatekeeper role in prescription drug abuse prevention","volume":"23","author":"Brushwood","year":"2017","journal-title":"Pharm Today"},{"issue":"2","key":"10.1016\/j.japh.2019.11.029_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.japh.2018.10.010","article-title":"Impact of community pharmacist intervention on concurrent benzodiazepine and opioid prescribing patterns","volume":"59","author":"Luchen","year":"2019","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"11","key":"10.1016\/j.japh.2019.11.029_bib11","first-page":"515","article-title":"A\u00a0randomized, pragmatic, pharmacist-led intervention reduced opioids following orthopedic surgery","volume":"24","author":"Smith","year":"2018","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.japh.2019.11.029_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sapharm.2015.05.001","article-title":"Developing a framework of care for opioid medication misuse in community pharmacy","volume":"12","author":"Cochran","year":"2016","journal-title":"Res Social Adm Pharm"},{"issue":"August","key":"10.1016\/j.japh.2019.11.029_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-015-0058-x","article-title":"Orienting patients to greater opioid safety: models of community pharmacy-based naloxone","volume":"12","author":"Green","year":"2015","journal-title":"Harm Reduct J"},{"issue":"6","key":"10.1016\/j.japh.2019.11.029_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1078155215607089","article-title":"Retrospective analysis of Pharmacist Interventions in an ambulatory palliative care practice","volume":"22","author":"Ma","year":"2016","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"suppl 2","key":"10.1016\/j.japh.2019.11.029_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","article-title":"Epidemiology of rheumatic diseases","volume":"39","author":"Sangha","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"2090-1542","key":"10.1016\/j.japh.2019.11.029_bib16","first-page":"584573","article-title":"The prevalence of fibromyalgia in other chronic pain conditions","volume":"2012","author":"Yunus","year":"2012","journal-title":"Pain Res Treat"},{"issue":"5","key":"10.1016\/j.japh.2019.11.029_bib17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10067-016-3239-4","article-title":"Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study","volume":"35","author":"Zamora-Legoff","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.japh.2019.11.029_bib18","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.40152","article-title":"Changing trends in opioid use among patients with rheumatoid arthritis in the United States","volume":"69","author":"Curtis","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.japh.2019.11.029_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.japh.2019.11.029_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"issue":"20","key":"10.1016\/j.japh.2019.11.029_bib21","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2009.723","article-title":"Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial","volume":"301","author":"Kroenke","year":"2009","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.japh.2019.11.029_bib22","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/00007632-200010150-00004","article-title":"Depression and chronic low back pain: establishing priorities in treatment","volume":"25","author":"Rush","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"10.1016\/j.japh.2019.11.029_bib23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists\u2019 role in opioid overdose: Kentucky pharmacists\u2019 willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119305370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319119305370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:46:51Z","timestamp":1761544011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319119305370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1544319119305370"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2019.11.029","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation and assessment of a pilot, community pharmacy\u2013based, opioid pain medication management program","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2019.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}